Congress Materials – Team PHenomenal Hope 2024
2024 Team PHenomenal Hope | Dec 6 | Boston, MA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Expert consensus on patient engagement strategies and shared decision-making to improve patient outcomes in pulmonary arterial hypertension
John J. Ryan, Sandra Lombardi, Rajan Saggar, Melisa Wilson, Christina Benninger, Jenny Lam, Gurinderpal Doad, Michelle Cho, Medi Stone, Daisy Bridge, Richard Perry, Ashley Enstone, Holly Smith, Lisa Perrett, Michelle Han
Methamphetamine-Associated Pulmonary Arterial Hypertension: Uncovering an Urgent Unmet Medical Need in the US via Analytics and Insights
Vinicio de Jesus Perez, John Kingrey, W. David Hardy, Gan Tan, Ankita Adhia, David Lopez, Michelle Cho, Marinella Sandros, Natalie Gearhart, Jenny Lam, John J. Ryan
Patient perspectives on fixed-dose combination therapy for pulmonary arterial hypertension: exploratory focus group insights
Jean M. Elwing, Stacey Barta, Tim Smith, Gabriela Gomez Rendon, David Lopez, Wesley Peters, Marinella Sandros, Akshay Muralidhar
Patient preferences regarding the use of combination ERA+PDE5i for the treatment of pulmonary arterial hypertension: Results from a discrete choice experiment.
Melisa Wilson, Nicholas A Kolaitis, Martha Kingman, Gabriela Gomez Rendon, David Lopez, Mohammad Rahman, Carly J Paoli, Ashley Martin, November McGarvey, Abraham Lee, Sana Mirza, Lana Melendres-Groves
Perceptions of the prostacyclin pathway: insights from a pulmonary arterial hypertension patient engagement research council
John W. McConnell, Michelle Han, Roland Massaad, Gurinderpal Doad
Predictive value of pulmonary artery pulsatility index in pulmonary arterial hypertension using the REVEAL Registry
Nicole F. Ruopp, Harrison Farber, Tobore Tobore, Mohammad Rahman, Joseph Yen, Navin K. Kapur, Zeenat Safdar
Prior authorization restrictiveness negatively impacts time to receipt of endothelin receptor antagonist therapy for pulmonary arterial hypertension
Murali Chakinala, Sumeet Panjabi, Jeremy Casorso, Safee Azam, Jennifer R Malinowski, Emma Holler, Vishal Kapoor, Josh Meyers, Ronald J Oudiz
Pulmonary arterial hypertension clinical trial endpoints and outcomes survey: patient perspectives and preferences
Mardi Gomberg-Maitland, Corey Ventetuolo, Ankita Adhia, Joseph Yen, John J. Ryan, Denise Lewis, Michelle Cho, Sumeet Panjabi, Rajan Saggar
Racial and Ethnic Differences in PAH Care: Insights from a Multicenter Study in the United States
Michelle Han, Gurinderpal Doad, Jenny Lam, Michelle Cho, Valeria Duan, Andrew Frick, Murali Chakinala, Harrison Farber
Through the patient lens: the diagnostic journey from connective tissue disease to pulmonary arterial hypertension
Kristin B. Highland, Rumon Chakravarty, Sylvia Georgi, Michelle Han
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.